Skip to main content
Top
Published in: Lung 2/2011

01-04-2011

Bronchoalveolar Lavage and Other Methods to Define the Human Respiratory Tract Milieu in Health and Disease

Author: Herbert Y. Reynolds

Published in: Lung | Issue 2/2011

Login to get access

Abstract

During fiber-optic bronchoscopy (FOB), surface sampling of the human respiratory airways and alveolar unit can be done with bronchoalveolar lavage (BAL), plus selective sites can be brushed for cells and transbronchial biopsies made in adjacent tissue. This permits analysis of the respiratory tract’s milieu in healthy normals, in those with disease, and in control subjects. These combined procedures have been an established approach for obtaining specimens for research and for clinical assessment for over four decades. However, now new less invasive sampling methods are emerging. This review emphasizes BAL and the cellular and noncellular components recovered in fluid that have contributed to improving knowledge of how the respiratory tree’s innate immunity can protect, and how airway structures can become deranged and manifest disease. After a discussion of training for FOB and procedural issues, a spectrum of respiratory diseases studied with BAL is presented, including airway illness (asthma and chronic obstructive pulmonary disease), diffuse interstitial lung diseases [idiopathic pulmonary fibrosis, rheumatoid interstitial lung disease (ILD), granulomatous ILDs], lung infections, lung malignancy, and upper and lower tract airway problems. Some recent studies with exhaled breath condensate analyses are given.
Literature
1.
go back to reference Simmons JG (2002) Hippocrates: rational medicine (460–370 B.C.). In: Doctors and discoveries: lives that created today’s medicine. Houghton Mifflin, Boston, pp 29–33 Simmons JG (2002) Hippocrates: rational medicine (460–370 B.C.). In: Doctors and discoveries: lives that created today’s medicine. Houghton Mifflin, Boston, pp 29–33
2.
go back to reference Simmons JG (2002) Claude Bernard (1813–1878)—Medicine and modern experimental physiology. In: Doctors and discoveries: lives that created today’s medicine. Houghton Mifflin, Boston, pp 14–17 Simmons JG (2002) Claude Bernard (1813–1878)—Medicine and modern experimental physiology. In: Doctors and discoveries: lives that created today’s medicine. Houghton Mifflin, Boston, pp 14–17
3.
go back to reference Reynolds HY (2004) President’s address: R.T.H. Laënnec, M.D.—clinicopathologic observations, using the stethoscope, made chest medicine more scientific. Trans Am Clin Climatol Assoc 115:1–29PubMed Reynolds HY (2004) President’s address: R.T.H. Laënnec, M.D.—clinicopathologic observations, using the stethoscope, made chest medicine more scientific. Trans Am Clin Climatol Assoc 115:1–29PubMed
4.
go back to reference Reynolds HY (1987) Bronchoalveolar lavage: state of art. Am Rev Respir Dis 135:250–263PubMed Reynolds HY (1987) Bronchoalveolar lavage: state of art. Am Rev Respir Dis 135:250–263PubMed
5.
go back to reference Reynolds HY (2000) Use of bronchoalveolar lavage in humans—past necessity and future imperative. Lung 178:271–293PubMedCrossRef Reynolds HY (2000) Use of bronchoalveolar lavage in humans—past necessity and future imperative. Lung 178:271–293PubMedCrossRef
6.
go back to reference Rottoli P, Bargagli E, Landi C, Magi B (2009) Proteomic analysis in interstitial lung diseases: a review. Curr Opin Pulm Med 15:470–478PubMedCrossRef Rottoli P, Bargagli E, Landi C, Magi B (2009) Proteomic analysis in interstitial lung diseases: a review. Curr Opin Pulm Med 15:470–478PubMedCrossRef
7.
go back to reference Reynolds HY (2001) Sampling local respiratory tract sites for inflammation. Sarcoidosis Vasc Diffuse Lung Dis 18:138–148PubMed Reynolds HY (2001) Sampling local respiratory tract sites for inflammation. Sarcoidosis Vasc Diffuse Lung Dis 18:138–148PubMed
8.
go back to reference Reynolds HY, Newball HH (1974) Analysis of proteins and respiratory cells obtained from human lungs by bronchial lavage. J Lab Clin Med 84:559–573PubMed Reynolds HY, Newball HH (1974) Analysis of proteins and respiratory cells obtained from human lungs by bronchial lavage. J Lab Clin Med 84:559–573PubMed
9.
go back to reference Busse WW, Wanner A, Adams K, Reynolds HY, Castro M, Chowdhury B, Kraft M, Levine RJ, Peters SP, Sullivan EJ (2005) NHLBI/NIAID workshop: investigative bronchoprovocation and bronchoscopy in airway diseases. Am J Respir Crit Care Med 172:807–816PubMedCrossRef Busse WW, Wanner A, Adams K, Reynolds HY, Castro M, Chowdhury B, Kraft M, Levine RJ, Peters SP, Sullivan EJ (2005) NHLBI/NIAID workshop: investigative bronchoprovocation and bronchoscopy in airway diseases. Am J Respir Crit Care Med 172:807–816PubMedCrossRef
10.
go back to reference Kazmierowski JA, Fauci AS, Reynolds HY (1976) Characterization of lymphocytes in bronchial lavage fluid from monkeys. J Immunol 116:615–618PubMed Kazmierowski JA, Fauci AS, Reynolds HY (1976) Characterization of lymphocytes in bronchial lavage fluid from monkeys. J Immunol 116:615–618PubMed
11.
go back to reference Reynolds HY (2008) Bronchoalveolar lavage-obtaining biological specimens from the respiratory tract surface. Sarcoidosis Vasc Diff Lung Dis 25:5–9 Reynolds HY (2008) Bronchoalveolar lavage-obtaining biological specimens from the respiratory tract surface. Sarcoidosis Vasc Diff Lung Dis 25:5–9
12.
13.
go back to reference Wahidi MM, Silvestri GA, Coakley RD, Ferguson JS, Shepherd RW, Moses L, Confori J, Que LG, Anstrom KJ, McGuire F, Colt H, Downie GH (2010) A prospective multi-center study of competency metrics and educational interventions in the learning of bronchoscopy among starting pulmonary fellows. Chest 137:1040–1049PubMedCrossRef Wahidi MM, Silvestri GA, Coakley RD, Ferguson JS, Shepherd RW, Moses L, Confori J, Que LG, Anstrom KJ, McGuire F, Colt H, Downie GH (2010) A prospective multi-center study of competency metrics and educational interventions in the learning of bronchoscopy among starting pulmonary fellows. Chest 137:1040–1049PubMedCrossRef
14.
go back to reference Yoneda KY, Morrissey BM (2008) The technique of adult flexible bronchoscopy: part 1. J Respir Dis 29:423–428 Yoneda KY, Morrissey BM (2008) The technique of adult flexible bronchoscopy: part 1. J Respir Dis 29:423–428
15.
go back to reference Buckley JD, Addrizzo-Harris DJ, Clay AS, Curtis JR, Kotloff RM, Lorin SM, Murin S, Sessler CN, Rogers PL, Rosen MJ, Spevetz A, King TE, Malhotra A, Parsons PE (2009) Multisociety task force recommendations of competencies in pulmonary and critical care medicine. Am J Respir Crit Care Med 180:290–295PubMedCrossRef Buckley JD, Addrizzo-Harris DJ, Clay AS, Curtis JR, Kotloff RM, Lorin SM, Murin S, Sessler CN, Rogers PL, Rosen MJ, Spevetz A, King TE, Malhotra A, Parsons PE (2009) Multisociety task force recommendations of competencies in pulmonary and critical care medicine. Am J Respir Crit Care Med 180:290–295PubMedCrossRef
16.
go back to reference Silvestri GA, Vincent BD, Wahidi MM, Robinette E, Hansbrough JR, Downie GH (2009) A phase 3, randomized, double-blind study to access the efficacy and safety of fospropofol disodium injection for moderate sedation in patients undergoing flexible bronchoscopy. Chest 135:41–47PubMedCrossRef Silvestri GA, Vincent BD, Wahidi MM, Robinette E, Hansbrough JR, Downie GH (2009) A phase 3, randomized, double-blind study to access the efficacy and safety of fospropofol disodium injection for moderate sedation in patients undergoing flexible bronchoscopy. Chest 135:41–47PubMedCrossRef
17.
go back to reference Baughman RP (2007) Technical aspects of bronchoalveolar lavage: recommendations for a standard procedure. Semin Respir Crit Care Med 28:475–485PubMedCrossRef Baughman RP (2007) Technical aspects of bronchoalveolar lavage: recommendations for a standard procedure. Semin Respir Crit Care Med 28:475–485PubMedCrossRef
18.
go back to reference Meyer KC (2007) Bronchoalveolar lavage as a diagnostic tool. Semin Respir Crit Care Med 28:546–560PubMedCrossRef Meyer KC (2007) Bronchoalveolar lavage as a diagnostic tool. Semin Respir Crit Care Med 28:546–560PubMedCrossRef
19.
go back to reference Rankin JA, Snyder PE, Schachter EN, Matthay RA (1984) Bronchoalveolar lavage. Its safety in subjects with mild asthma. Chest 85:723–728PubMedCrossRef Rankin JA, Snyder PE, Schachter EN, Matthay RA (1984) Bronchoalveolar lavage. Its safety in subjects with mild asthma. Chest 85:723–728PubMedCrossRef
20.
go back to reference Metzger WJ, Richerson HB, Worden K, Monick M, Hunninghake GW (1986) Bronchoalveolar lavage of allergic asthmatic patients following allergen bronchoprovocation. Chest 89:477–483PubMedCrossRef Metzger WJ, Richerson HB, Worden K, Monick M, Hunninghake GW (1986) Bronchoalveolar lavage of allergic asthmatic patients following allergen bronchoprovocation. Chest 89:477–483PubMedCrossRef
21.
go back to reference Metzger WJ, Nugent K, Richerson HB, Moseley P, Lakin R, Zavala D, Hunninghake GW (1985) Methods for bronchoalveolar lavage in asthmatic patients following bronchoprovocation and local antigen challenge. Chest 87(Suppl):16S–19SPubMedCrossRef Metzger WJ, Nugent K, Richerson HB, Moseley P, Lakin R, Zavala D, Hunninghake GW (1985) Methods for bronchoalveolar lavage in asthmatic patients following bronchoprovocation and local antigen challenge. Chest 87(Suppl):16S–19SPubMedCrossRef
22.
go back to reference Bernstein IL, Boushey HA, Cherniack RM, other Workshop Participants (1985) NHLBI Workshop summary and recommendations of a workshop on the investigative use of fiberoptic bronchoscopy and bronchoalveolar lavage in asthmatics. Am Rev Respir Dis 132:180–182 Bernstein IL, Boushey HA, Cherniack RM, other Workshop Participants (1985) NHLBI Workshop summary and recommendations of a workshop on the investigative use of fiberoptic bronchoscopy and bronchoalveolar lavage in asthmatics. Am Rev Respir Dis 132:180–182
23.
go back to reference Woodruff PG, Modrek B, Choy DF, Jia G, Abbas AR, Ellwanger A, Koth LL, Arron JR, Fahy JV (2009) T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med 180:388–395PubMedCrossRef Woodruff PG, Modrek B, Choy DF, Jia G, Abbas AR, Ellwanger A, Koth LL, Arron JR, Fahy JV (2009) T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med 180:388–395PubMedCrossRef
24.
go back to reference Thunberg S, Gafvelin G, Nord M, Grönneberg R, Grunewald J, Eklund A, van Hage M (2010) Allergen provocation increases Th2-cytokines and FOXP3 expression in the asthmatic lung. Allergy 65:311–318PubMedCrossRef Thunberg S, Gafvelin G, Nord M, Grönneberg R, Grunewald J, Eklund A, van Hage M (2010) Allergen provocation increases Th2-cytokines and FOXP3 expression in the asthmatic lung. Allergy 65:311–318PubMedCrossRef
25.
go back to reference Punturieri A, Croxton TL, Weinmann G, Kiley JP (2007) The changing face of COPD (editorial). Am Fam Physician 75:315–316PubMed Punturieri A, Croxton TL, Weinmann G, Kiley JP (2007) The changing face of COPD (editorial). Am Fam Physician 75:315–316PubMed
26.
go back to reference Turner MC, Chen Y, Krewski D, Calle EE, Thun MJ (2007) Chronic obstructive pulmonary disease is associated with lung cancer mortality in a prospective study of never smokers. Am J Respir Crit Care Med 176:285–290PubMedCrossRef Turner MC, Chen Y, Krewski D, Calle EE, Thun MJ (2007) Chronic obstructive pulmonary disease is associated with lung cancer mortality in a prospective study of never smokers. Am J Respir Crit Care Med 176:285–290PubMedCrossRef
27.
go back to reference Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, Paré PD (2004) The nature of small-airway obstruction in chronic obstructive pulmonary disease. New Engl J Med 350:2645–2653PubMedCrossRef Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, Paré PD (2004) The nature of small-airway obstruction in chronic obstructive pulmonary disease. New Engl J Med 350:2645–2653PubMedCrossRef
28.
go back to reference Curtis JL, Freeman CM, Hogg JC (2007) The immunopathogenesis of chronic obstructive pulmonary disease: insights from recent research. Proc Am Thorac Soc 4:512–521PubMedCrossRef Curtis JL, Freeman CM, Hogg JC (2007) The immunopathogenesis of chronic obstructive pulmonary disease: insights from recent research. Proc Am Thorac Soc 4:512–521PubMedCrossRef
29.
go back to reference Murphy TF, Brauer AL, Eschberger K, Lobbins P, Grove L, Cai X, Sethi S (2008) Pseudomonas aeruginosa in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 177:853–860PubMedCrossRef Murphy TF, Brauer AL, Eschberger K, Lobbins P, Grove L, Cai X, Sethi S (2008) Pseudomonas aeruginosa in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 177:853–860PubMedCrossRef
30.
go back to reference Sethi S, Sethi R, Eschberger K, Lobbins P, Cai X, Grant BJ, Murphy TF (2007) Airway bacterial concentrations and exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 176:356–361PubMedCrossRef Sethi S, Sethi R, Eschberger K, Lobbins P, Cai X, Grant BJ, Murphy TF (2007) Airway bacterial concentrations and exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 176:356–361PubMedCrossRef
31.
go back to reference MacNee W (2008) Update in chronic obstructive pulmonary disease 2007. Am J Respir Crit Care Med 177:820–829PubMedCrossRef MacNee W (2008) Update in chronic obstructive pulmonary disease 2007. Am J Respir Crit Care Med 177:820–829PubMedCrossRef
32.
go back to reference Hodge S, Hodge G, Jersmann H, Matthews G, Ahern J, Holmes M, Reynolds PN (2008) Azithromycin improves macrophage phagocytic function and expression of mannose receptor in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 178:139–148PubMedCrossRef Hodge S, Hodge G, Jersmann H, Matthews G, Ahern J, Holmes M, Reynolds PN (2008) Azithromycin improves macrophage phagocytic function and expression of mannose receptor in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 178:139–148PubMedCrossRef
33.
go back to reference Crystal RG, Randall SH, Engelhardt JF, Voynow J, Sunday ME (2008) Airway epithelial cells—current concepts and challenges. Proc Am Thorac Soc 5:772–777PubMedCrossRef Crystal RG, Randall SH, Engelhardt JF, Voynow J, Sunday ME (2008) Airway epithelial cells—current concepts and challenges. Proc Am Thorac Soc 5:772–777PubMedCrossRef
34.
go back to reference Ammous Z, Hackett NR, Butler MW, Raman T, Dolgalev I, O’Connor TP, Harvey BG, Crystal RG (2008) Variability in small airway epithelial gene expression among normal smokers. Chest 133:1344–1353PubMedCrossRef Ammous Z, Hackett NR, Butler MW, Raman T, Dolgalev I, O’Connor TP, Harvey BG, Crystal RG (2008) Variability in small airway epithelial gene expression among normal smokers. Chest 133:1344–1353PubMedCrossRef
35.
go back to reference Hunninghake GW, Kawanami O, Ferrans VJ, Young RC Jr, Roberts WC, Crystal RG (1981) Characterization of inflammatory and immune effector cells in the lung parenchyma of patients with interstitial lung disease. Am Rev Respir Dis 123:407–412PubMed Hunninghake GW, Kawanami O, Ferrans VJ, Young RC Jr, Roberts WC, Crystal RG (1981) Characterization of inflammatory and immune effector cells in the lung parenchyma of patients with interstitial lung disease. Am Rev Respir Dis 123:407–412PubMed
36.
go back to reference Crystal RG, Bitterman PR, Rennard SI, Hance AJ, Keogh BA (1984) Interstitial lung diseases of unknown cause: disorders characterized by chronic inflammation of the lower respiratory tract. N Engl J Med 310:154–166, 235–244 Crystal RG, Bitterman PR, Rennard SI, Hance AJ, Keogh BA (1984) Interstitial lung diseases of unknown cause: disorders characterized by chronic inflammation of the lower respiratory tract. N Engl J Med 310:154–166, 235–244
37.
go back to reference Daniele RP, Elias JA, Epstein PE, Rossman MD (1985) Bronchoalveolar lavage: role in the pathogenesis, diagnosis, and management of interstitial lung disease. Ann Intern Med 102:93–108PubMed Daniele RP, Elias JA, Epstein PE, Rossman MD (1985) Bronchoalveolar lavage: role in the pathogenesis, diagnosis, and management of interstitial lung disease. Ann Intern Med 102:93–108PubMed
38.
go back to reference Drent M, van Nierop MA, Gerritsen FA, Wouters EF, Mulder PG (1996) A computer program using BALF-analysis results as a diagnostic tool in interstitial lung diseases. Am J Respir Crit Care Med 153:736–741PubMed Drent M, van Nierop MA, Gerritsen FA, Wouters EF, Mulder PG (1996) A computer program using BALF-analysis results as a diagnostic tool in interstitial lung diseases. Am J Respir Crit Care Med 153:736–741PubMed
39.
go back to reference Reynolds HY (2009) Present status of bronchoalveolar lavage in interstitial lung disease. Curr Opin Pulm Dis 15:479–485CrossRef Reynolds HY (2009) Present status of bronchoalveolar lavage in interstitial lung disease. Curr Opin Pulm Dis 15:479–485CrossRef
41.
go back to reference Kinder BW, Shariat C, Collard HR, Koth LL, Wolters PJ, Golden JA, Panos RJ, King TE Jr (2010) Undifferentiated connective tissue disease-associated interstitial lung disease: changes in lung function. Lung 188:143–149PubMedCrossRef Kinder BW, Shariat C, Collard HR, Koth LL, Wolters PJ, Golden JA, Panos RJ, King TE Jr (2010) Undifferentiated connective tissue disease-associated interstitial lung disease: changes in lung function. Lung 188:143–149PubMedCrossRef
42.
go back to reference Reynolds HY (1998) Diagnostic and management strategies for diffuse interstitial lung disease. Chest 113:192–202PubMedCrossRef Reynolds HY (1998) Diagnostic and management strategies for diffuse interstitial lung disease. Chest 113:192–202PubMedCrossRef
43.
go back to reference Antin-Ozerkis D, Rubinowitz A (2008) Recognizing lung disease in patients with rheumatoid arthritis. Part 1: pleuropulmonary disease may be more common than you thought. J Respir Dis 29:274–280 Antin-Ozerkis D, Rubinowitz A (2008) Recognizing lung disease in patients with rheumatoid arthritis. Part 1: pleuropulmonary disease may be more common than you thought. J Respir Dis 29:274–280
44.
go back to reference Antin-Ozerkis D, Rubinowitz A (2008) Recognizing lung disease in patients with rheumatoid arthritis. Part 2. J Respir Dis 29:318–324 Antin-Ozerkis D, Rubinowitz A (2008) Recognizing lung disease in patients with rheumatoid arthritis. Part 2. J Respir Dis 29:318–324
45.
go back to reference Tashkin DP, Elashoff R, Clements PJ, Golden J, Roth MD, Furst DE, Arriola E, Silver R, Strange C, Bolster M, Seibold JR, Riley DJ, Hsu VM, Varga J, Schraufnagel DE, Theodore A, Simms R, Wise R, Wigley F, White B, Steen V, Read C, Mayes M, Parsley E, Mubarak K, Connolly MK, Golden J, Olman M, Fessler B, Rothfield N, Metersky M, Scleroderma Lung Study Research Group (2006) Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med 354:2655–2666PubMedCrossRef Tashkin DP, Elashoff R, Clements PJ, Golden J, Roth MD, Furst DE, Arriola E, Silver R, Strange C, Bolster M, Seibold JR, Riley DJ, Hsu VM, Varga J, Schraufnagel DE, Theodore A, Simms R, Wise R, Wigley F, White B, Steen V, Read C, Mayes M, Parsley E, Mubarak K, Connolly MK, Golden J, Olman M, Fessler B, Rothfield N, Metersky M, Scleroderma Lung Study Research Group (2006) Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med 354:2655–2666PubMedCrossRef
46.
go back to reference Strange C, Bolster MB, Roth MD, Silver RM, Theodore A, Goldin J, Clements P, Chung J, Elashoff RM, Suh R, Smith EA, Furst DE, Tashkin DP, Scleroderma Lung Study Reserch Group (2008) Bronchoalveolar lavage and response to cyclophosphamide in scleroderma interstitial lung disease. Am J Respir Crit Care Med 177:91–98PubMedCrossRef Strange C, Bolster MB, Roth MD, Silver RM, Theodore A, Goldin J, Clements P, Chung J, Elashoff RM, Suh R, Smith EA, Furst DE, Tashkin DP, Scleroderma Lung Study Reserch Group (2008) Bronchoalveolar lavage and response to cyclophosphamide in scleroderma interstitial lung disease. Am J Respir Crit Care Med 177:91–98PubMedCrossRef
47.
go back to reference Nagai S, Handa T, Ito Y, Takeuchi M, Izumi T (2007) Bronchoalveolar lavage in idiopathic interstitial lung diseases. Semin Respir Crit Care Med 28:496–503PubMedCrossRef Nagai S, Handa T, Ito Y, Takeuchi M, Izumi T (2007) Bronchoalveolar lavage in idiopathic interstitial lung diseases. Semin Respir Crit Care Med 28:496–503PubMedCrossRef
48.
go back to reference Wang Y, Kuan PJ, Xing C, Cronkhite JT, Torres F, Rosenblatt RL, DiMaio JM, Kinch LN, Grishin NV, Garcia CK (2009) Genetic defects in surfactant protein A2 are associated with pulmonary fibrosis and lung cancer. Am J Hum Genet 84:52–59PubMedCrossRef Wang Y, Kuan PJ, Xing C, Cronkhite JT, Torres F, Rosenblatt RL, DiMaio JM, Kinch LN, Grishin NV, Garcia CK (2009) Genetic defects in surfactant protein A2 are associated with pulmonary fibrosis and lung cancer. Am J Hum Genet 84:52–59PubMedCrossRef
49.
go back to reference Rosas IO, Richards TJ, Konishi K, Zhang Y, Gibson K, Lokshin AE, Lindell KO, Cisneros J, Macdonald SD, Pardo A, Sciurba F, Dauber J, Selman M, Gochuico BR, Kaminski N (2008) MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis. PLoS Med 5:623–633CrossRef Rosas IO, Richards TJ, Konishi K, Zhang Y, Gibson K, Lokshin AE, Lindell KO, Cisneros J, Macdonald SD, Pardo A, Sciurba F, Dauber J, Selman M, Gochuico BR, Kaminski N (2008) MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis. PLoS Med 5:623–633CrossRef
50.
go back to reference Vasakova M, Sterclova M, Kolesart L, Slavcev A, Pohunek P, Sulc J, Skibova J, Striz I (2009) Bronchoalveolar lavage fluid cellular characteristics, functional parameters and cytokine and chemokine levels in interstitial lung diseases. Scand J Immunol 69:268–274PubMedCrossRef Vasakova M, Sterclova M, Kolesart L, Slavcev A, Pohunek P, Sulc J, Skibova J, Striz I (2009) Bronchoalveolar lavage fluid cellular characteristics, functional parameters and cytokine and chemokine levels in interstitial lung diseases. Scand J Immunol 69:268–274PubMedCrossRef
51.
go back to reference Shinoda H, Tasaka S, Fujishima S, Yamasawa W, Miyamoto K, Nakano Y, Kamata H, Hasegawa N, Ishizaka A (2009) Elevated CC chemokine levels in bronchoalveolar lavage fluid is predictive of a poor outcome of idiopathic pulmonary fibrosis. Respiration 78:285–292PubMedCrossRef Shinoda H, Tasaka S, Fujishima S, Yamasawa W, Miyamoto K, Nakano Y, Kamata H, Hasegawa N, Ishizaka A (2009) Elevated CC chemokine levels in bronchoalveolar lavage fluid is predictive of a poor outcome of idiopathic pulmonary fibrosis. Respiration 78:285–292PubMedCrossRef
52.
go back to reference Ohshimo S, Bonella F, Cui A, Beume M, Kohno N, Guzman J, Costabel U (2009) Significance of bronchoalveolar lavage for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 179:1043–1047PubMedCrossRef Ohshimo S, Bonella F, Cui A, Beume M, Kohno N, Guzman J, Costabel U (2009) Significance of bronchoalveolar lavage for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 179:1043–1047PubMedCrossRef
53.
go back to reference Kawabata Y, Takermura T, Hebisawa A, Ogura T, Yamaguchi T, Kuriyama T, Nagai S, Sakatani M, Chida K, Sakai F, Park J, Colby TV (2008) Eosinophilia in bronchoalveolar lavage fluid and architectural destruction are features of desquamative interstitial pneumonia. Histopathology 52:194–202PubMedCrossRef Kawabata Y, Takermura T, Hebisawa A, Ogura T, Yamaguchi T, Kuriyama T, Nagai S, Sakatani M, Chida K, Sakai F, Park J, Colby TV (2008) Eosinophilia in bronchoalveolar lavage fluid and architectural destruction are features of desquamative interstitial pneumonia. Histopathology 52:194–202PubMedCrossRef
54.
go back to reference Reynolds HY (2008) Respiratory structure and function: mechanisms and testing. In: Goldman L, Ausiello D (eds) Cecil medicine, 23rd edn. Saunders Elsevier, Philadelphia, pp 602–609 Reynolds HY (2008) Respiratory structure and function: mechanisms and testing. In: Goldman L, Ausiello D (eds) Cecil medicine, 23rd edn. Saunders Elsevier, Philadelphia, pp 602–609
55.
go back to reference Reynolds HY, Fulmer JD, Kazmierowski JA, Roberts WC, Frank MM, Crystal RG (1977) Analysis of cellular and protein content of bronchoalveolar lavage fluid from patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis. J Clin Invest 59:165–175PubMedCrossRef Reynolds HY, Fulmer JD, Kazmierowski JA, Roberts WC, Frank MM, Crystal RG (1977) Analysis of cellular and protein content of bronchoalveolar lavage fluid from patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis. J Clin Invest 59:165–175PubMedCrossRef
56.
go back to reference Drake WP, Newman LS (2006) Mycobacterial antigens may be important in sarcoidosis pathogenesis. Curr Opin Pulm Med 12:359–363PubMedCrossRef Drake WP, Newman LS (2006) Mycobacterial antigens may be important in sarcoidosis pathogenesis. Curr Opin Pulm Med 12:359–363PubMedCrossRef
58.
go back to reference Reynolds HY (2002) Sarcoidosis: impact of other illness on the presentation and management of multiorgan disease. Lung 180:281–299PubMedCrossRef Reynolds HY (2002) Sarcoidosis: impact of other illness on the presentation and management of multiorgan disease. Lung 180:281–299PubMedCrossRef
59.
go back to reference Grunewald J, Eklund A (2009) Löfgren’s syndrome: human leukocyte antigen strongly influences the disease course. Am J Respir Crit Care Med 179:301–312 Grunewald J, Eklund A (2009) Löfgren’s syndrome: human leukocyte antigen strongly influences the disease course. Am J Respir Crit Care Med 179:301–312
60.
go back to reference Reynolds HY, Peavy HH, Gail DB, Kiley JP (2006) Review: past achievements and future directions of sarcoidosis research: a NHLBI perspective. Sarcoidosis Vasc Diffuse Lung Dis 23:83–91PubMed Reynolds HY, Peavy HH, Gail DB, Kiley JP (2006) Review: past achievements and future directions of sarcoidosis research: a NHLBI perspective. Sarcoidosis Vasc Diffuse Lung Dis 23:83–91PubMed
61.
go back to reference Drent M, Mansour K, Linssen C (2007) Bronchoalveolar lavage in sarcoidosis. Semin Respir Crit Care Med 28:486–495PubMedCrossRef Drent M, Mansour K, Linssen C (2007) Bronchoalveolar lavage in sarcoidosis. Semin Respir Crit Care Med 28:486–495PubMedCrossRef
62.
go back to reference Culver DA, Barna BP, Raychaudhuri B, Bonifield TL, Abraham S, Malur A, Farver CF, Kavuru MS, Thomassen MJ (2004) Peroxisome proliferator-activated receptor-gamma activity is deficient in alveolar macrophages in pulmonary sarcoidosis. Am J Respir Cell Mol Biol 30:1–5PubMedCrossRef Culver DA, Barna BP, Raychaudhuri B, Bonifield TL, Abraham S, Malur A, Farver CF, Kavuru MS, Thomassen MJ (2004) Peroxisome proliferator-activated receptor-gamma activity is deficient in alveolar macrophages in pulmonary sarcoidosis. Am J Respir Cell Mol Biol 30:1–5PubMedCrossRef
63.
go back to reference Hart CM, Roman J, Reddy R, Sime PJ (2008) PPARγ: a novel molecular target in lung disease. J Invest Med 56:515–517 Hart CM, Roman J, Reddy R, Sime PJ (2008) PPARγ: a novel molecular target in lung disease. J Invest Med 56:515–517
64.
go back to reference Bonfield TL, Farver CF, Barna BP, Malur A, Abraham S, Raychaudhuri B, Kavuru MS, Thomassen MJ (2003) Peroxisome proliferator-activated receptor-gamma is deficient in alveolar macrophages from patients with alveolar proteinosis. Am J Respir Cell Mol Biol 29:677–682PubMedCrossRef Bonfield TL, Farver CF, Barna BP, Malur A, Abraham S, Raychaudhuri B, Kavuru MS, Thomassen MJ (2003) Peroxisome proliferator-activated receptor-gamma is deficient in alveolar macrophages from patients with alveolar proteinosis. Am J Respir Cell Mol Biol 29:677–682PubMedCrossRef
65.
go back to reference Ichikawa H, Kataoka M, Hiramatsu J, Ohmori M, Tanimoto Y, Kanehiro A, Nakata Y, Tanimoto M (2008) Quantitative analysis of propionibacterial DNA in bronchoalveolar lavage cells from patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 25:15–20PubMed Ichikawa H, Kataoka M, Hiramatsu J, Ohmori M, Tanimoto Y, Kanehiro A, Nakata Y, Tanimoto M (2008) Quantitative analysis of propionibacterial DNA in bronchoalveolar lavage cells from patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 25:15–20PubMed
66.
go back to reference Danila E, Norkūniene J, Jurgauskiene L, Malickaite R (2009) Diagnostic role of BAL fluid CD4/CD8 ratio in different radiographic and clinical forms of pulmonary sarcoidosis. Clin Respir J 3:214–221 Danila E, Norkūniene J, Jurgauskiene L, Malickaite R (2009) Diagnostic role of BAL fluid CD4/CD8 ratio in different radiographic and clinical forms of pulmonary sarcoidosis. Clin Respir J 3:214–221
67.
go back to reference Piotrowski WJ, Kurmanowska Z, Antczak A, Marczak J, Ciebiada M, Górski P (2010) Exhaled 8-isoprostane in sarcoidosis: relation to superoxide anion production by bronchoalveolar lavage cells. Inflamm Res 59:1027–1032PubMedCrossRef Piotrowski WJ, Kurmanowska Z, Antczak A, Marczak J, Ciebiada M, Górski P (2010) Exhaled 8-isoprostane in sarcoidosis: relation to superoxide anion production by bronchoalveolar lavage cells. Inflamm Res 59:1027–1032PubMedCrossRef
68.
go back to reference Lockstone HE, Sanderson S, Kulakova N, Baban D, Leonard A, Kok WL, McGowan S, McMichael AJ, Ho LP (2010) Gene set analysis of lung samples provides insight into pathogenesis of progressive, fibrotic pulomonary sarcoidosis. Am J Respir Crit Care Med 181(12):1367–1375PubMedCrossRef Lockstone HE, Sanderson S, Kulakova N, Baban D, Leonard A, Kok WL, McGowan S, McMichael AJ, Ho LP (2010) Gene set analysis of lung samples provides insight into pathogenesis of progressive, fibrotic pulomonary sarcoidosis. Am J Respir Crit Care Med 181(12):1367–1375PubMedCrossRef
69.
go back to reference Cordeiro CR, Jones JC, Alfaro T, Ferreina AJ (2007) Bronchoalveolar lavage in occupational lung diseases. Semin Respir Crit Care Med 28:504–513PubMedCrossRef Cordeiro CR, Jones JC, Alfaro T, Ferreina AJ (2007) Bronchoalveolar lavage in occupational lung diseases. Semin Respir Crit Care Med 28:504–513PubMedCrossRef
70.
go back to reference Selman M, Lacasse Y, Pardo A, Cormier Y (2010) Hypersensitivity pneumonitis caused by fungi. Proc Am Thorac Soc 7:229–236PubMedCrossRef Selman M, Lacasse Y, Pardo A, Cormier Y (2010) Hypersensitivity pneumonitis caused by fungi. Proc Am Thorac Soc 7:229–236PubMedCrossRef
71.
go back to reference Reynolds HY (1988) Hypersensitivity pneumonitis: correlation of cellular and immunologic changes with clinical phases of disease. Lung 166:189–208PubMedCrossRef Reynolds HY (1988) Hypersensitivity pneumonitis: correlation of cellular and immunologic changes with clinical phases of disease. Lung 166:189–208PubMedCrossRef
72.
go back to reference Fink JN, Ortega HG, Reynolds HY, Cormier Y, Fan LL, Franks TJ, Kreiss K, Kunkel S, Lynch D, Quirce S, Rose C, Schleimer RP, Schuyler MR, Selman M, Trout D, Yoshizawa Y (2005) NHLBI workshop: needs and opportunities for research in hypersensitivity pneumonitis. Am J Respir Crit Care Med 171:792–798PubMedCrossRef Fink JN, Ortega HG, Reynolds HY, Cormier Y, Fan LL, Franks TJ, Kreiss K, Kunkel S, Lynch D, Quirce S, Rose C, Schleimer RP, Schuyler MR, Selman M, Trout D, Yoshizawa Y (2005) NHLBI workshop: needs and opportunities for research in hypersensitivity pneumonitis. Am J Respir Crit Care Med 171:792–798PubMedCrossRef
73.
go back to reference Lacasse Y, Selman M, Costabel U, Dalphin JC, Morell F, Erkinjuntti-Pekkanen R, Mueller NL, Colby TV, Schuyler M, Jomphe V, Cormier Y, Study Group HP (2009) Classification of hypersensitivity pneumonitis: a hypothesis. Int Arch Allergy Immunol 149:161–166PubMedCrossRef Lacasse Y, Selman M, Costabel U, Dalphin JC, Morell F, Erkinjuntti-Pekkanen R, Mueller NL, Colby TV, Schuyler M, Jomphe V, Cormier Y, Study Group HP (2009) Classification of hypersensitivity pneumonitis: a hypothesis. Int Arch Allergy Immunol 149:161–166PubMedCrossRef
74.
go back to reference Morell F, Roger A, Reyes L, Cruz MJ, Murio C, Muñoz X (2008) Bird fancier’s lung: a series of 86 patients. Medicine 87:110–130PubMedCrossRef Morell F, Roger A, Reyes L, Cruz MJ, Murio C, Muñoz X (2008) Bird fancier’s lung: a series of 86 patients. Medicine 87:110–130PubMedCrossRef
75.
go back to reference Costabel U, Guzman J, Bonella F, Oshimo S (2007) Bronchoalveolar lavage in other interstitial lung diseases. Semin Respir Crit Care Med 28:514–524PubMedCrossRef Costabel U, Guzman J, Bonella F, Oshimo S (2007) Bronchoalveolar lavage in other interstitial lung diseases. Semin Respir Crit Care Med 28:514–524PubMedCrossRef
76.
go back to reference Majori M, Poletti V, Curti A, Corradi M, Falcone F, Pesci A (2000) Bronchoalveolar lavage in bronchiolitis obliterans organizing pneumonia primed by radiation therapy to the breast. J Allergy Clin Immunol 105:239–244PubMedCrossRef Majori M, Poletti V, Curti A, Corradi M, Falcone F, Pesci A (2000) Bronchoalveolar lavage in bronchiolitis obliterans organizing pneumonia primed by radiation therapy to the breast. J Allergy Clin Immunol 105:239–244PubMedCrossRef
77.
go back to reference Poletti V, Poletti G, Murer B, Saragoni L, Chilosi M (2007) Bronchoalveolar lavage in malignancy. Semin Respir Crit Care Med 28:534–545PubMedCrossRef Poletti V, Poletti G, Murer B, Saragoni L, Chilosi M (2007) Bronchoalveolar lavage in malignancy. Semin Respir Crit Care Med 28:534–545PubMedCrossRef
78.
79.
go back to reference Wilkes DS, Egan TM, Reynolds HY (2005) NHLBI Workshop: lung transplantation—opportunities for research and clinical advancement. Am J Respir Crit Care Med 172:944–955PubMedCrossRef Wilkes DS, Egan TM, Reynolds HY (2005) NHLBI Workshop: lung transplantation—opportunities for research and clinical advancement. Am J Respir Crit Care Med 172:944–955PubMedCrossRef
80.
81.
go back to reference Iacono AT, Johnson BA, Grgurich WF, Youssef JG, Corcoran TE, Seiler DA, Dauber JH, Smaldone GC, Zeevi A, Yousem SA, Fung JJ, Burckart GJ, McCurry KR, Griffith BP (2006) A randomized trial of inhaled cyclosporine in lung-transplant recipients. N Engl J Med 354:141–150PubMedCrossRef Iacono AT, Johnson BA, Grgurich WF, Youssef JG, Corcoran TE, Seiler DA, Dauber JH, Smaldone GC, Zeevi A, Yousem SA, Fung JJ, Burckart GJ, McCurry KR, Griffith BP (2006) A randomized trial of inhaled cyclosporine in lung-transplant recipients. N Engl J Med 354:141–150PubMedCrossRef
82.
go back to reference Belperio JA, Weigt SS, Fishbein MC, Lynch JP III (2009) Chronic lung allograft rejection: mechanisms and therapy. Proc Am Thorac Soc 6:108–121PubMedCrossRef Belperio JA, Weigt SS, Fishbein MC, Lynch JP III (2009) Chronic lung allograft rejection: mechanisms and therapy. Proc Am Thorac Soc 6:108–121PubMedCrossRef
83.
go back to reference Muylem AV, Knoop C, Estenne M (2007) Early detection of chronic pulmonary allograft dysfunction by exhaled biomarkers. Am J Respir Crit Care Med 175:731–736PubMedCrossRef Muylem AV, Knoop C, Estenne M (2007) Early detection of chronic pulmonary allograft dysfunction by exhaled biomarkers. Am J Respir Crit Care Med 175:731–736PubMedCrossRef
84.
go back to reference Christie JD, Shah CV, Kawut SM, Mangalmurti N, Lederer DJ, Sonett JR, Ahya VN, Palmer SM, Wille K, Lama V, Shah PD, Shah A, Weinacker A, Deutschman CS, Kohl BA, Demissie E, Bellamy S, Ware LB, Lung Transplant Outcomes Group (2009) Plasma levels of receptor for advanced glycation end products, blood transfusion, and risk of primary graft dysfunction. Am J Respir Crit Care Med 180:1010–1015PubMedCrossRef Christie JD, Shah CV, Kawut SM, Mangalmurti N, Lederer DJ, Sonett JR, Ahya VN, Palmer SM, Wille K, Lama V, Shah PD, Shah A, Weinacker A, Deutschman CS, Kohl BA, Demissie E, Bellamy S, Ware LB, Lung Transplant Outcomes Group (2009) Plasma levels of receptor for advanced glycation end products, blood transfusion, and risk of primary graft dysfunction. Am J Respir Crit Care Med 180:1010–1015PubMedCrossRef
85.
go back to reference Wilkes DS (2009) Primary graft dysfunction: it’s all the RAGE (editorial). Am J Respir Crit Care Med 180:915–919PubMedCrossRef Wilkes DS (2009) Primary graft dysfunction: it’s all the RAGE (editorial). Am J Respir Crit Care Med 180:915–919PubMedCrossRef
86.
go back to reference Avila M, Ojcius DM, Yilmaz Ö (2009) The oral microbiota: living with a permanent guest. DNA Cell Biol 25:405–411CrossRef Avila M, Ojcius DM, Yilmaz Ö (2009) The oral microbiota: living with a permanent guest. DNA Cell Biol 25:405–411CrossRef
87.
go back to reference Young KR Jr, Rankin JA, Naegel GP, Paul ES, Reynolds HY (1985) Bronchoalveolar lavage cells and proteins in patients with the acquired immunodeficiency syndrome. Ann Intern Med 103:522–533PubMed Young KR Jr, Rankin JA, Naegel GP, Paul ES, Reynolds HY (1985) Bronchoalveolar lavage cells and proteins in patients with the acquired immunodeficiency syndrome. Ann Intern Med 103:522–533PubMed
88.
go back to reference Jafari C, Thijsen S, Sotgiu G, Goletti D, Benítez JA, Losi M, Eberhardt R, Kirsten D, Kalsdorf B, Bossink A, Latorre I, Migliori GB, Strassburg A, Winteroll S, Greinert U, Richeldi L, Ernst M, Lange C, Tuberculosis Network European Trialsgroup (2009) Bronchoalveolar lavage enzyme-linked immunospot for rapid diagnosis of tuberculosis (A Tuberculosis Network European Trials Group Study). Am J Respir Crit Care Med 180:666–673PubMedCrossRef Jafari C, Thijsen S, Sotgiu G, Goletti D, Benítez JA, Losi M, Eberhardt R, Kirsten D, Kalsdorf B, Bossink A, Latorre I, Migliori GB, Strassburg A, Winteroll S, Greinert U, Richeldi L, Ernst M, Lange C, Tuberculosis Network European Trialsgroup (2009) Bronchoalveolar lavage enzyme-linked immunospot for rapid diagnosis of tuberculosis (A Tuberculosis Network European Trials Group Study). Am J Respir Crit Care Med 180:666–673PubMedCrossRef
89.
go back to reference Tunney MM, Field TR, Moriarty TF, Patrick S, Doering G, Muhlebach MS, Wolfgang MC, Boucher R, Gilpin DF, McDowell A, Elborn JS (2008) Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis. Am J Respir Crit Care Med 177:995–1001PubMedCrossRef Tunney MM, Field TR, Moriarty TF, Patrick S, Doering G, Muhlebach MS, Wolfgang MC, Boucher R, Gilpin DF, McDowell A, Elborn JS (2008) Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis. Am J Respir Crit Care Med 177:995–1001PubMedCrossRef
90.
go back to reference Fasano MB (2010) Combined airway: impact of upper airway on lower airway. Curr Opin Otolaryngol Head Neck Surg 18:15–20PubMedCrossRef Fasano MB (2010) Combined airway: impact of upper airway on lower airway. Curr Opin Otolaryngol Head Neck Surg 18:15–20PubMedCrossRef
91.
go back to reference Boujaoude ZC, Bartter TC, Pratter MR, Fasano MB (2008) Tips on the management of rhinosinusitis. J Respir Dis 29:353–359 Boujaoude ZC, Bartter TC, Pratter MR, Fasano MB (2008) Tips on the management of rhinosinusitis. J Respir Dis 29:353–359
92.
go back to reference Mahesh PA, Vedanthan PK, Holla AD (2009) Time interval and the factors associated with the development of asthma in patients with allergic rhinitis. Lung 187:393–400PubMedCrossRef Mahesh PA, Vedanthan PK, Holla AD (2009) Time interval and the factors associated with the development of asthma in patients with allergic rhinitis. Lung 187:393–400PubMedCrossRef
93.
go back to reference Schleimer RP, Kato A, Peters A, Conley D, Kim J, Liu MC, Harris KE, Kuperman DA, Chandra R, Favoreto S Jr, Avila PC, Grammer LC, Kern RC (2009) Epithelium, inflammation, and immunity in the upper airways of humans. Proc Am Thorac Soc 6:288–294PubMedCrossRef Schleimer RP, Kato A, Peters A, Conley D, Kim J, Liu MC, Harris KE, Kuperman DA, Chandra R, Favoreto S Jr, Avila PC, Grammer LC, Kern RC (2009) Epithelium, inflammation, and immunity in the upper airways of humans. Proc Am Thorac Soc 6:288–294PubMedCrossRef
94.
go back to reference Ciarleglio G, Refini RM, Pieroni MG, Martino VA, Bargagli E, Rottoli P, Sestini P (2008) Exhaled carbon monoxide in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 25:46–50PubMed Ciarleglio G, Refini RM, Pieroni MG, Martino VA, Bargagli E, Rottoli P, Sestini P (2008) Exhaled carbon monoxide in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 25:46–50PubMed
95.
go back to reference Corradi M, Pignatti P, Brunetti G, Goldoni M, Caglieri A, Nava S, Moscato G, Balbi B (2008) Comparison between exhaled and bronchoalveolar lavage levels of hydrogen peroxide in patients with diffuse interstitial lung diseases. ACTA Biomed 79(suppl):73–78PubMed Corradi M, Pignatti P, Brunetti G, Goldoni M, Caglieri A, Nava S, Moscato G, Balbi B (2008) Comparison between exhaled and bronchoalveolar lavage levels of hydrogen peroxide in patients with diffuse interstitial lung diseases. ACTA Biomed 79(suppl):73–78PubMed
96.
go back to reference Pérez-de-Llano LA, Carballada F, Castro Añón O, Pizarro M, Golpe R, Baloira A, Vázquez Caruncho M, Boquete M (2010) Exhaled nitric oxide predicts controls in patients with difficult-to-treat asthma. Eur Respir J 35(6):1221–1227PubMedCrossRef Pérez-de-Llano LA, Carballada F, Castro Añón O, Pizarro M, Golpe R, Baloira A, Vázquez Caruncho M, Boquete M (2010) Exhaled nitric oxide predicts controls in patients with difficult-to-treat asthma. Eur Respir J 35(6):1221–1227PubMedCrossRef
97.
go back to reference Esther CR Jr, Boysen G, Olsen BM, Collins LB, Ghio AJ, Swenberg JW, Boucher RC (2009) Mass spectrometric analysis of biomarkers and dilution markers in exhaled breath condensate reveals elevated purines in asthma and cystic fibrosis. Am J Physiol Lung Cell Mol Physiol 296:L987–L993PubMedCrossRef Esther CR Jr, Boysen G, Olsen BM, Collins LB, Ghio AJ, Swenberg JW, Boucher RC (2009) Mass spectrometric analysis of biomarkers and dilution markers in exhaled breath condensate reveals elevated purines in asthma and cystic fibrosis. Am J Physiol Lung Cell Mol Physiol 296:L987–L993PubMedCrossRef
98.
go back to reference Fens N, Zwinderman AH, Van der Schee MP, de Nijs SB, Dijkers E, Roldaan AC, Cheung D, Bel EH, Sterk PJ (2009) Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma. Am J Respir Crit Care Med 180:1076–1082PubMedCrossRef Fens N, Zwinderman AH, Van der Schee MP, de Nijs SB, Dijkers E, Roldaan AC, Cheung D, Bel EH, Sterk PJ (2009) Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma. Am J Respir Crit Care Med 180:1076–1082PubMedCrossRef
99.
go back to reference Machado RF (2009) Identifying chronic obstructive pulmonary disease and asthma by exhaled breath analysis (editorial). Am J Respir Crit Care Med 180:1038–1039PubMedCrossRef Machado RF (2009) Identifying chronic obstructive pulmonary disease and asthma by exhaled breath analysis (editorial). Am J Respir Crit Care Med 180:1038–1039PubMedCrossRef
100.
101.
go back to reference Barnes PJ, Dweik RA, Gelb AF, Gibson PG, George SC, Grasemann H, Pavord ID, Ratjen F, Silkoff PE, Taylor DR, Zamel N (2010) Exhaled nitric oxide in pulmonary diseases: a comprehensive review. Chest 138:682–692PubMedCrossRef Barnes PJ, Dweik RA, Gelb AF, Gibson PG, George SC, Grasemann H, Pavord ID, Ratjen F, Silkoff PE, Taylor DR, Zamel N (2010) Exhaled nitric oxide in pulmonary diseases: a comprehensive review. Chest 138:682–692PubMedCrossRef
102.
go back to reference Lázár Z, Cervenak L, Orosz M, Gálffy G, Komlósi ZI, Bikov A, Losonczy G, Horváth I (2010) Adenosine triphosphate concentration of exhaled breath condensate in asthma. Chest 138:536–542PubMedCrossRef Lázár Z, Cervenak L, Orosz M, Gálffy G, Komlósi ZI, Bikov A, Losonczy G, Horváth I (2010) Adenosine triphosphate concentration of exhaled breath condensate in asthma. Chest 138:536–542PubMedCrossRef
103.
go back to reference Lin JL, Bonnichsen MH, Nogeh EU, Raftery MJ, Thomas PS (2010) Proteomics in detection and monitoring of asthma and smoking-related lung diseases. Expert Rev Proteomics 7(3):361–372PubMedCrossRef Lin JL, Bonnichsen MH, Nogeh EU, Raftery MJ, Thomas PS (2010) Proteomics in detection and monitoring of asthma and smoking-related lung diseases. Expert Rev Proteomics 7(3):361–372PubMedCrossRef
104.
go back to reference Reynolds HY, Chrétien J (1984) Respiratory tract fluids: analysis of content and contemporary use in understanding lung diseases. Dis Mon 30(5):3–103 Reynolds HY, Chrétien J (1984) Respiratory tract fluids: analysis of content and contemporary use in understanding lung diseases. Dis Mon 30(5):3–103
105.
go back to reference Reynolds HY, Merrill WW (1981) Airway changes in young smokers that may antedate chronic obstructive lung disease. Med Clin North Am 65:667–689PubMed Reynolds HY, Merrill WW (1981) Airway changes in young smokers that may antedate chronic obstructive lung disease. Med Clin North Am 65:667–689PubMed
106.
107.
go back to reference Franks TJ, Colby TV, Travis WD, Tuder RM, Reynolds HY, Brody AR, Cardoso WV, Crystal RG, Drake CJ, Engelhardt J, Frid M, Herzog E, Mason R, Phan SH, Randell SH, Rose MC, Stevens T, Serge J, Sunday ME, Voynow JA, Weinstein BM, Whitsett J, Williams MC (2008) Resident cellular components of the human lung: current knowledge and goals for research on cell phenotyping and function. Proc Am Thorac Soc 5:763–766PubMedCrossRef Franks TJ, Colby TV, Travis WD, Tuder RM, Reynolds HY, Brody AR, Cardoso WV, Crystal RG, Drake CJ, Engelhardt J, Frid M, Herzog E, Mason R, Phan SH, Randell SH, Rose MC, Stevens T, Serge J, Sunday ME, Voynow JA, Weinstein BM, Whitsett J, Williams MC (2008) Resident cellular components of the human lung: current knowledge and goals for research on cell phenotyping and function. Proc Am Thorac Soc 5:763–766PubMedCrossRef
108.
go back to reference Guo YL, Chen YQ, Wang K, Qin SM, Wu C, Kong JL (2010) Accuracy of BAL galactomannan in diagnosing invasive aspergillosis: a bivariate metaanalysis and systemic review. Chest 138:817–824PubMedCrossRef Guo YL, Chen YQ, Wang K, Qin SM, Wu C, Kong JL (2010) Accuracy of BAL galactomannan in diagnosing invasive aspergillosis: a bivariate metaanalysis and systemic review. Chest 138:817–824PubMedCrossRef
109.
go back to reference Jayaraman S, Gayathri AR, Kumar PS, Santosham R, Santosham R, Narasimhan R (2010) Whole lung lavage for pulmonary alveolar proteinosis. Lung India 27:33–36PubMedCrossRef Jayaraman S, Gayathri AR, Kumar PS, Santosham R, Santosham R, Narasimhan R (2010) Whole lung lavage for pulmonary alveolar proteinosis. Lung India 27:33–36PubMedCrossRef
Metadata
Title
Bronchoalveolar Lavage and Other Methods to Define the Human Respiratory Tract Milieu in Health and Disease
Author
Herbert Y. Reynolds
Publication date
01-04-2011
Publisher
Springer-Verlag
Published in
Lung / Issue 2/2011
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-011-9284-5

Other articles of this Issue 2/2011

Lung 2/2011 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.